AC
UTHR icon

Allstate Corporation’s United Therapeutics UTHR Stock Holding History

Allstate Corporation’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.79M Buy
4,710
+1,615
+52% +$804K 0.03% 396
2025
Q4 		$1.51M Buy
3,095
+1,631
+111% +$760K 0.02% 435
2025
Q3 		$614K Buy
+1,464
New +$492K 0.01% 477
2025
Q2 		– Sell
-1,930
Closed -$595K – 544
2025
Q1 		$595K Buy
1,930
+754
+64% +$258K 0.02% 472
2024
Q4 		$415K Buy
+1,176
New +$432K 0.01% 529
2017
Q3 		– Sell
-6,111
Closed -$793K – 246
2017
Q2 		$793K Buy
+6,111
New +$762K 0.04% 267

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return